Delivery Order SPE2DB25D3404-SPE2DB25FUPLM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Vyvanse 30 mg capsules (100-count units) at a ceiling value of $2,079.25. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025. The award represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends...
- The Defense Logistics Agency awarded a delivery order valued at $18,788.88 to AmerisourceBergen Drug Corp for the supply of Vyvanse 20 mg capsules (100-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Vyvanse 20 mg capsules (100-count units) with a ceiling value of $1,469.34. This non-set-aside, competitively awarded contract employs firm fixed pricing and requires completion by July 21, 2025. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Vyvanse 10 mg capsules (100-count units) with a contract ceiling value of $1,333.84. This is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and carries no set-aside designation, indicating it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $3,152.00 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Vyvanse 20 mg capsules (100-count units). This is a firm fixed price contract with an ultimate completion date of July 28, 2025, and represents a non-competitive set-aside delivery order. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,939.79 to AmerisourceBergen Drug Corp for Vyvanse 20 mg capsules (100-count units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award issued under a larger contract vehicle. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,327.58 to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Vyvanse 20 mg capsules (100-count units). This is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor responsible for fulfillment. This delivery order is issued under the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,337.70 on July 21, 2025, for the supply of Vyvanse 20 mg capsules (100-count units). This firm fixed-price delivery order, which is expected to be completed by July 22, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vyvanse is a prescription medication commonly used in...
- The Defense Logistics Agency awarded a delivery order valued at $1,339.21 to AmerisourceBergen Drug Corp for Vyvanse 50 mg capsules (100-count packages) on July 21, 2025, with an ultimate completion date of July 22, 2025. The contract employs firm fixed pricing and is not set aside for any specific business category. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal healthcare vendor specializing in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Vyvanse 40 mg capsules (100-count units) under a firm fixed-price contract with a ceiling value of $3,369.46. This non-set-aside award, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania,...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB25FUPLMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Vyvanse 20 mg capsules (100 count) with a ceiling value of $4,284.71. This is a firm fixed price delivery order with an ultimate completion date of July 28, 2025. The award was competitively procured with no set-aside designation, and performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The company leverages its comprehensive DLA Troop Support Medical IDC to supply a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. This specific delivery order for Vyvanse, a controlled pharmaceutical used in treating attention deficit hyperactivity disorder (ADHD), demonstrates the company's continued role as a critical vendor within the federal medical supply chain and reflects DLA's ongoing procurement strategies to support military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 7/25/25 |